News
Important Only
Recursion climbs as experimental drug reduces polyp growth in rare disease trial
Shares of drug developer Recursion Pharma RXRX.O rise 6.2% to $5.05 premarketCo says its experimental oral drug, REC-4881, helped reduce abnormal growths, called polyps, in the colon of patients with a rare genetic condition called familial adenomatous polyposisIn an early to mid-stage trial, 9 out ...Reuters
Mon, Dec 8
LIVE MARKETS-US investors get most bang for buck beyond Wall St
STOXX 600 flat U.S. futures up slightly Magnum lists after spinoff from Unilever Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonreuters.com. US INVESTORS GET MOST BANG FOR BUCK BEYOND WALL ...Reuters
Mon, Dec 8
CoreWeave announces $2 bln convertible debt offering; shares fall
AI cloud infrastructure provider CoreWeave's CRWV.O shares fall 5.5% to $83.40 premarketCRWV announces proposed private offering of senior convertible notes worth $2 billion, due 2031Co intends to use the net proceeds to fund the cost of entering into capped call transactions and general corpora...Reuters
Mon, Dec 8
Yardeni cools on 'Magnificent 7' after 15 years of tech optimism
Dec 8 (Reuters) - Yardeni Research is no longer "overweight" on the "Magnificent 7", ending a 15-year bullish stance on U.S. tech stocks on worries over elevated concentration and opportunities in the broader market.The research firm, founded by Wall Street veteran Ed Yardeni, now re...Reuters
Mon, Dec 8
LYC HEALTHCARE Announces US IPO Of 3,000,000 Class A Shares
Dec 8 (Reuters) - LYC HEALTHCARE (CAYMAN) LTD : ANNOUNCES US IPO OF 3,000,000 CLASS A SHARESLYC HEALTHCARE (CAYMAN) LTD - IPO PRICE RANGE BETWEEN $4.00 AND $6.00 PER SHARE - SEC FILINGLYC HEALTHCARE (CAYMAN) LTD: AC SUNSHINE SECURITIES LLC IS UNDERWRITER TO IPOLYC HEALTHCARE (CAYMAN) LTD: HAVE APPLI...Reuters
Mon, Dec 8
US STOCKS-U.S. stock futures inch up as investors await Fed rate‑cut decision
Futures up: Dow 0.05%, S&P 500 0.1%, Nasdaq 0.2%Marvell Technology falls after S&P 500 inclusion snub Confluent jumps after report IBM nears $11 bln buyout dealBy Johann M Cherian and Pranav Kashyap Dec 8 (Reuters) - U.S. stock index futures were marginally higher on Monday, as invest...Reuters
Mon, Dec 8
Pre-Bell｜U.S. Futures Edge Up; Confluent Surges 29%; Kymera Therapeutics Rockets 28%; Carvana Jumps 9%; Broadcom Rises over 2%; Tesla Falls 1.6%; CoreWeave Drops 6%
U.S. stock index futures edged higher on Monday, supported by expectations that the Federal Reserve will deliver a long-awaited interest rate cut later this week at a meeting widely seen as one of the most divisive in recent history.Market SnapshotAt 8:30 a.m. ET, Dow e-minis were up 3 points, or 0....Tiger News
Mon, Dec 8
Barclays lifts Compass to 'overweight'; shares rise
Shares of U.S. residential real estate brokerage firm Compass COMP.N up about 3% at nearly $11 premarketBarclays upgrades rating to "overweight" from "equal-weight", raises PT to $13 from $9Brokerage says co's upgrade reflects synergies from its HOUS deal, stronger agent value, a...Reuters
Mon, Dec 8
Kymera Therapeutics rises after positive data for eczema drug
Shares of Kymera Therapeutics KYMR.O rise 5.6% to $70.32 premarketKYMR says its experimental oral treatment for eczema eased symptoms and itching in a small early-stage study, while also helping patients who had asthma or hay feverThe company tested the drug, KT-621, in 22 people with moderate-to-se...Reuters
Mon, Dec 8
Ocular Therapeutix rises on plans to fast-track FDA filing for eye disease drug
Shares of Ocular Therapeutix OCUL.O rise 13.5% to $14.28 in premarket tradingOCUL says its plans to submit a marketing application for its experimental eye disease drug, Axpaxli, to treat wet age-related macular degeneration after one-year data from its ongoing late-stage trial, expected in the firs...Reuters
Mon, Dec 8
NextEra Energy gains on Google deal expansion
Shares of utility NextEra Energy NEE.N up 2% at $84.74 premarketCo expands partnership with Google Cloud to scale multiple gigawatts (GW) of data center capacity and energy infrastructure across the U.S.Up to last close, stock was up ~16% YTDReuters
Mon, Dec 8
Marvell Technology falls after S&P 500 inclusion snub
Shares of chipmaker Marvell Technology MRVL.O drop 6.4% to $92.6 premarket Late on Friday, S&P Dow Jones Indices announced that Carvana CVNA.N, CRH CRH.Nand Comfort Systems USA FIX.N will join S&P 500 indexOn Friday, MRVL was one of the largest S&P 500 eligible new add by market capitali...Reuters
Mon, Dec 8
Stocks hold ground as markets eye Fed rate cut
LONDON/SYDNEY, Dec 8 (Reuters) - Stocks held their ground on Monday as markets bet that the Federal Reserve would deliver a rate cut this week, though investors speculated that the meeting could be one of the most fractious in recent memory.Reuters
Mon, Dec 8
Agios Pharma falls after FDA misses decision deadline on blood-disorder drug filing
Shares of drugmaker Agios Pharma AGIO.O fall 7.5% to $25.6 premarketAgios Pharmaceuticals says U.S. regulators have not yet made a decision on expanding the use of its rare blood disease drug mitapivat to patients with thalassemia, even though a target review date passed last weekThe drug mitapivat,...Reuters
Mon, Dec 8
Micron rises as brokerages raise PTs on AI-driven memory demand
Memory chipmaker Micron Technology's MU.O shares rise 2.5% to $243.13 premarketSusquehanna raises PT to $300 from $200 — implying an upside of 26.5% to the stock's last close — on stronger expected avg selling prices for dynamic random access memory and flash memory, driven by tight supply f...
Reuters
Mon, Dec 8
Lennar falls as Barclays cuts it to 'underweight'
Shares of U.S. homebuilder Lennar LEN.N down 1.5% at $122 premarketBarclays downgrades rating to "underweight" from "equal-weight", raises PT to $98 from $95New PT shows a downside of 20.9% from the stock's last closeBrokerage says co's rigid production model and high valuati...Reuters
Mon, Dec 8
JP Morgan changes PT and rating on energy cos citing supply risks
J.P. Morgan changes PT and rating on oil and gas companies citing supply side risks and long-awaited demand inflection for natural gasBrokerage says the magnitude of the oversupply plus the potential easing of geopolitical tensions would make this a speculative call at bestSees potential for global ...Reuters
Mon, Dec 8
Central bank body BIS raises concerns of gold and stocks double bubble
Central bank body BIS flags gold market concernsExplosive co-movement with stocks not seen for at least 50 yearsPoints to 'growing fragility' of risk-on environmentBy Marc Jones LONDON, Dec 8 (Reuters) - The combination of gold and share prices soaring in unison is a phenomenon not seen i...Reuters
Mon, Dec 8
Structure Therapeutics down ahead of weight-loss drug data
Shares of Structure Therapeutics GPCR.O falls 1.4% to $34.1 premarket The drug developer on December 8 is set to release data from a study evaluating its experimental drug aleniglipron, a once-daily oral for the treatment of obesityThe current landscape for obesity treatments includes Danish drugmak...Reuters
Mon, Dec 8
